Boston Scientific
837 hedge funds and large institutions have $45.8B invested in Boston Scientific in 2020 Q2 according to their latest regulatory filings, with 114 funds opening new positions, 353 increasing their positions, 245 reducing their positions, and 67 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.23% more ownership
Funds ownership: 91.05% → 91.28% (+0.23%)
26% less funds holding in top 10
Funds holding in top 10: 23 → 17 (-6)
43% less call options, than puts
Call options by funds: $202M | Put options by funds: $357M
Holders
837
Holding in Top 10
17
Calls
$202M
Puts
$357M
Top Buyers
| 1 | +$628M | |
| 2 | +$478M | |
| 3 | +$478M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$419M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$292M |
Top Sellers
| 1 | -$1.26B | |
| 2 | -$481M | |
| 3 | -$308M | |
| 4 |
Jennison Associates
New York
|
-$291M |
| 5 |
SCM
Suvretta Capital Management
New York
|
-$147M |